Impact of diclofenac use on the incidence and severity of ischemic colitis: A systematic rewiew
DOI:
https://doi.org/10.56294/shp2025196Keywords:
Colitis, Ischemia, Diclofenac, Colon, Nonsteroidal anti-inflammatory agentsAbstract
Introduction: Ischemic colitis is inflammation of the colon caused by decreased blood flow, being the most frequent form of intestinal ischemia. Symptoms can be mild to severe complications such as intestinal perforation. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), which is commonly used, has been associated with various gastrointestinal complications. Currently, several studies have suggested a possible relationship between diclofenac use and ischemic colitis. Objective: To evaluate the impact of diclofenac use on the incidence and severity of ischemic colitis through a systematic review of the available scientific literature.
Materials and Methods: An exhaustive search of databases such as Pudmed and Scielo was performed to identify relevant studies that analyzed the relationship between diclofenac use and ischemic colitis, using the following terms: “Colitis”; “Ischemia”; “Diclofenac”; “Colon”; “Anti-Inflammatory Agents, Non- Steroidal”. Observational studies, clinical trials and case reports were included. Data were extracted and analyzed to assess the incidence and severity of ischemic colitis in patients treated with diclofenac.
Results: The articles reviewed indicate a significant relationship between the use of diclofenac and the appearance of ischemic colitis. Bielsa Martín et al. (2006) presented specific cases of acute colitis induced by diclofenac. Gleeson and Davis (2003), together with Sierra Gabarda et al. (2022) found a correlation between the use of NSAIDs and the recent diagnosis of ischemic colitis. The proposed mechanisms involve inhibition of prostaglandin synthesis, which affects intestinal mucosal integrity and blood perfusion
Conclusion: This systematic review emphasizes the significant impact of diclofenac on the incidence and severity of ischemic colitis. It is recommended that clinicians cautiously evaluate the need to prescribe diclofenac, considering therapeutic alternatives with less risk and monitoring those patients with risk factors. In addition, further research is needed to confirm a conclusive causal relationship and to develop preventive and therapeutic strategies to help reduce the risks associated with diclofenac use.
References
1. Washington C, Carmichael JC. Management of ischemic colitis. Clin Colon Rectal Surg. 2012 Dec;25(4):228–35.
2. Brandt LJ, Feuerstadt P, Longstreth GF, Boley SJ, American College of Gastroenterology. ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI). Am J Gastroenterol. 2015 Jan;110(1):18–44; quiz 45.
3. Theodoropoulou A, Koutroubakis IE. Ischemic colitis: clinical practice in diagnosis and treatment. World J Gastroenterol. 2008 Dec 28;14(48):7302–8.
4. Pérez Ruiz AA, López Mantecón AM, Grau León I. Antiinflamatorios no esteroideos (AINES): consideraciones para su uso estomatológico. Rev Cubana Estomatol. 2002 Aug;39(2):119–38.
5. Bielsa Martín S, Porcel Pérez JM, Madroñero Vuelta AB, Planella Rubinat MJ. Colitis aguda por diclofenaco. Rev Esp Enferm Dig. 2006 Mar;98(3):226–7. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082006000300015
6. Gleeson MH, Davis AJ. Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study. Aliment Pharmacol Ther. 2003 Mar 15;17(6):817–25. doi: 10.1046/j.1365-2036.2003.01519.x. PMID: 12641504.
7. Sierra Gabarda O, Espinosa Pérez M, Casas Deza D, Lamuela Calvo LJ, Llorente Barrio M, Monzón Báez RM, et al. NSAID-induced ischemic colitis. Rev Esp Enferm Dig. 2022 May;114(5):307. doi: 10.17235/reed.2022.8605/2022. PMID: 35067065.
8. Vieth M. NSAR-Kolopathie [NSAID-colonopathy]. Pathologe. 2006 Feb;27(1):65–72. German. doi: 10.1007/s00292-005-0810-1. PMID: 16369762.
9. Gleeson MH, Davis AJ. Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study. Aliment Pharmacol Ther. 2003 Mar 15;17(6):817–25. doi: 10.1046/j.1365-2036.2003.01519.x. PMID: 12641504.
10. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993 Jun;104(6):1832–47. doi: 10.1016/0016-5085(93)90667-2. PMID: 8500743.
11. Byrne MF, McGuinness J, Smyth CM, Manning DS, Sheehan KM, Bohra SG, et al. Nonsteroidal anti-inflammatory drug-induced diaphragms and ulceration in the colon. Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1265–9. doi: 10.1097/00042737-200211000-00017. PMID: 12439124.
12. Katsinelos P, Christodoulou K, Pilpilidis I, Xiarchos P, Papagiannis A, Dimiropoulos S, et al. Colopathy associated with the systemic use of nonsteroidal antiinflammatory medications: an underestimated entity. Hepatogastroenterology. 2002 Mar-Apr;49(44):345–8. PMID: 11995447.
Published
Issue
Section
License
Copyright (c) 2025 Luciano Josué Loyola Bolognesi, Marcelo Adrián Estrin (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
